Participants with NAFLD showed significantly higher weight, BMI, waist circumference, MBP, plasma glucose, insulin, HOMA-IR, serum total cholesterol, AST and ALT levels, and lower proportion without chronic disease than participants without NAFLD in both men and women. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.